Guan Wei-jie, Shi Xu, Jiang Cai-yu, Xie Yan-qing, Zhu Zheng, Gao Yi, Zheng Jin-ping
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
Clin Respir J. 2016 Mar;10(2):176-80. doi: 10.1111/crj.12199. Epub 2014 Sep 3.
Correlation between fractional exhaled nitric oxide (FeNO) and responsiveness to inhaled leukotriene D4 (LTD4 ) and methacholine (MCh) might be different. This study aims to determine the correlation between FeNO and airway responsiveness to LTD4 and MCh, and to compare the airway responsiveness to inhaled LTD4 and MCh and FeNO in non-smokers, patients without rhinitis and non-smokers without rhinitis.
In this cross-over study, asthmatic patients and healthy subjects underwent LTD4 and MCh inhalation challenge at a 2- to 14-day interval. The FeNO was measured by using NIOX MINO, a portable instrument, at the initial visit, before spirometry and inhalation challenge tests. Subgroup analyses were performed in asthmatic patients based on the categorisation of never-smoker group, non-rhinitis group and never-smoker without rhinitis group.
Of 62 asthmatic patients enrolled, 43 did not have self-reported rhinitis (asthmatic patients without rhinitis), 56 were never-smokers (asthmatic non-smokers), giving rise to 37 non-smokers who did not have rhinitis (asthmatic non-smokers without rhinitis). Twenty-one healthy subjects were enrolled. Overall, Log10 FeNO correlated with Log10 PD20 FEV1 -MCh but not Log10 PD20 FEV1 -LTD4 or Log10 (LTD4 /MCh potency ratio). Reduced FeNO was associated with significantly higher Log10 PD20 FEV1 -MCh but not Log10 PD20 FEV1 -LTD4 , except for non-smokers. Compared with all asthmatic patients, asthmatic non-smokers without rhinitis were characterised by markedly reduced levels of Log10 PD20 FEV1 -MCh but not Log10 PD20 FEV1 -LTD4 . The difference in all parameters did not reach statistical significance among asthmatic patients without rhinitis, asthmatic non-smokers and asthmatic non-smokers without rhinitis.
FeNO correlates with airway responsiveness to inhaled MCh but not LTD4 , in asthmatic patients, particularly in asthmatic non-smokers without rhinitis.
呼出一氧化氮分数(FeNO)与对吸入白三烯D4(LTD4)和乙酰甲胆碱(MCh)的反应性之间的相关性可能有所不同。本研究旨在确定FeNO与气道对LTD4和MCh的反应性之间的相关性,并比较非吸烟者、无鼻炎患者以及无鼻炎的非吸烟者对吸入LTD4和MCh的气道反应性及FeNO水平。
在这项交叉研究中,哮喘患者和健康受试者每隔2至14天接受一次LTD4和MCh吸入激发试验。在初次就诊时,于肺量计检查和吸入激发试验前,使用便携式仪器NIOX MINO测量FeNO。根据从不吸烟者组、无鼻炎组和无鼻炎的从不吸烟者组对哮喘患者进行亚组分析。
在纳入的62例哮喘患者中,43例无自我报告的鼻炎(无鼻炎的哮喘患者),56例从不吸烟(哮喘非吸烟者),从而产生了37例无鼻炎的非吸烟者(无鼻炎的哮喘非吸烟者)。纳入21名健康受试者。总体而言,Log10 FeNO与Log10 PD20 FEV1 - MCh相关,但与Log10 PD20 FEV1 - LTD4或Log10(LTD4 / MCh效价比)无关。除非吸烟者外,FeNO降低与显著更高的Log10 PD20 FEV1 - MCh相关,但与Log10 PD20 FEV1 - LTD4无关。与所有哮喘患者相比,无鼻炎的哮喘非吸烟者的特征是Log10 PD20 FEV1 - MCh水平显著降低,但Log10 PD20 FEV1 - LTD4未降低。在无鼻炎的哮喘患者、哮喘非吸烟者和无鼻炎的哮喘非吸烟者之间,所有参数的差异均未达到统计学意义。
在哮喘患者中,尤其是在无鼻炎的哮喘非吸烟者中,FeNO与气道对吸入MCh的反应性相关,但与LTD4无关。